Like Oncoverse

closed 4/24/2017 via BNC Analysis

BTG International Ltd., purchased Oncoverse from Wanda Health

synopsis: NetScientific said portfolio company Wanda has sold OncoVerse LLC to BTG Plc. OncoVerse is a digital health platform designed to allow cancer patients' care teams to collaborate and allow clinicians across all disciplines to work together to determine the most effective treatment plan for their patients.
buyer: BTG International Ltd. (LSE:BTG:$646.34)
BTG is focused on developing innovative products in specialist areas of medicine to better serve doctors and patients. Their growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins. "
seller parent: NetScientific
seller: Wanda Health
San Francisco-based Oncoverse, LLC is a digital health care platform company which enables health care professionals to collaborate on cancer patient care decisions, and to monitor the progress of patient therapies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/14/2021 via PR Newswire

Global Healthcare Exchange, LLC, acquired Explorer Surgical Corp.

synopsis: Global Healthcare Exchange (GHX), a provider of healthcare supply chain solutions, has acquired Explorer Surgical Corp., a digital and remote case support platform for surgical teams. Explorer's cloud-based platform enables medical device teams and providers to remotely share best practices and collaborate in real-time during a live procedure.
buyer parent: Temasek Holdings
buyer: Global Healthcare Exchange, LLC
Global Healthcare Exchange, LLC (GHX) drives costs out of healthcare with cloud-based supply chain management technology and services in order to help enable better patient care and savings by maximizing automation, efficiency and accuracy of business processes. "
target: Explorer Surgical Corp.
Explorer Surgical is a digital and remote case support platform for surgical teams. Explorer's cloud-based platform enables medical device teams and providers to remotely share best practices and collaborate in real-time during a live procedure.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/16/2014 via BusinessWire

iCAD, Inc., will acquire DermEbx and Radion

synopsis: iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the treatment of cancer, announced the signing of a definitive agreement to acquire DermEbx, a leading electronic brachytherapy services and technology provider, and Radion, Inc., a cloud-based oncology collaboration software solution.
buyer: iCAD, Inc. (ICAD:$47.24)
iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. "
target: DermEbx and Radion
Radion, Inc. created products and solutions for cancer patient-care paths so more patients receive timely, effective, quality treatments. DermEbx is a leading healthcare services and technology company dedicated to offering skin electronic brachytherapy programs to dermatology and oncology networks.
price ($mm)
$13
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/19/2021 via BNC Analysis

Revenio Group, will acquire Oculo

synopsis: Revenio Group, a global leader in ophthalmic diagnostics and ophthalmic devices, will acquire Oculo, an Australian teleophthalmology and clinical communication platform company. Oculo's cloud-based platform enables eye care teams to securely share clinical imaging, referrals, and other clinical correspondence.
buyer: Revenio Group (HLSE:REG1V:$72.76)
Revenio Group is a global leader in ophthalmic diagnostics and ophthalmic devices. Revenio's eye diagnostics solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. Their tools are used to detect and diagnose glaucoma. "
target: Oculo
Oculo is an Australian teleophthalmology and clinical communication platform company. Oculo's cloud-based platform enables eye care teams to securely share clinical imaging, referrals, and other clinical correspondence. Their technology enhances collaboration and delivers efficient patient care.
price ($mm)
$14
rev ($mm)
$1
EBITDA ($mm)
EV / rev
11.5x
EV / EBITDA
closed 1/31/2018 via GlobeNewswire

Inspirata, Inc., acquired Omnyx

synopsis: Cancer informatics solution provider Inspirata, announced that it has acquired Omnyx from GE Healthcare. Omnyx has brought software to pathology departments around the world. The company’s flagship digital pathology software product, Dynamyx, enhances the pathology workflow by providing new channels for collaboration and tools to boost efficiency.
buyer: Inspirata, Inc.
Inspirata, Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis. The solution accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic & predictive assays, & remote consultations. "
target parent: General Electric Company
target: Omnyx
Omnyx, a digital pathology company, has helped transform the way pathologists worldwide work and collaborate. Through its Precision Solution that includes the brilliant Dynamyx software and consulting, all members of the cancer care team can work together to enhance patient outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/9/2014 via Company Press Release

Box Inc., acquired MedXT

synopsis: MedXT, a pioneer in cloud-based medical image viewing, sharing and collaboration, has been acquired by Box, a provider of a secure, scalable content-sharing platform. Founders of MedXT will join Box's engineering organization to help integrate their technology with the Box platform and build all-new content experiences for the healthcare industry.
buyer: Box Inc. (BOX:$755.44)
Box provides a secure, scalable content-sharing platform. Box's flexible content management solution lets users access and share content from anywhere, on any device – while providing IT visibility into how content moves within their organizations and beyond. "
target: MedXT
San Francisco-based MedXT brings the power of radiology information systems/Picture archiving and communications systems to clinics and practices by enabling radiologists and practitioners to evaluate, diagnose and treat patients remotely using its easy to use, flexible universal image viewer.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/5/2015 via BusinessWire

XIFIN, Inc., acquired VisualShare

synopsis: XIFIN, Inc., the healthcare cloud computing company revolutionizing the business of healthcare diagnostics from patient to payment, announced the acquisition of VisualShare, a Salt Lake City-based medical informatics company specializing in diagnostic image management.
buyer parent: GTCR, LLC
buyer: XIFIN, Inc.
XIFIN is an innovative software and services company dedicated to optimizing the economics of healthcare. XIFIN’s technology solutions, business intelligence, and HEO platform are used by a broad range of the nation’s largest and most complex diagnostic service providers. "
target: VisualShare
VisualShare is a Salt Lake City-based medical informatics company specializing in diagnostic image management. VisualShare provides a cloud-based medical imaging management solution and image collaboration platform that integrates imaging and text into a consolidated record.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/26/2016 via BusinessWire

lifeIMAGE, Inc., acquired Mammosphere

synopsis: lifeIMAGE, the nation’s largest medical image exchange platform that enables imaging data interoperability across healthcare networks, providers and patients, announced that it has acquired Mammosphere, the leading national medical exchange network specializing in mammography and women’s imaging.
buyer: lifeIMAGE, Inc.
lifeIMAGE is an interoperable medical image sharing network that helps healthcare providers access their patients’ imaging records, regardless of where exams are performed or stored. "
target: Mammosphere
Mammosphere is the leading national medical exchange network specializing in mammography and women’s imaging.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/25/2021 via BusinessWire

K Health Inc., acquired Trusst

synopsis: K Health, a data-driven virtual primary care platform, has acquired Trusst, the mental health app connecting people and providers for on-demand text-based therapy. The acquisition of Trusst will expand K Health’s mental health offering and give people the option of a trusted, vetted clinician to turn to 24/7 for therapy and medication.
buyer: K Health Inc.
K Health is a digital healthcare company on a mission to use the power of shared knowledge to get everyone access to better, affordable healthcare. K Health is a free tool that uses AI to help people understand how doctors diagnose and treat those with similar symptoms and conditions. "
target: Trusst
Trusst is a secure messaging-only platform that connects people with a licensed therapist in their state. Using the Trusst app, those looking for therapeutic support can get started with a leading provider right away using messaging-based conversations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2019 via BNC Analysis

Mynavi Corporation, acquired ExMed.io

synopsis: Mynavi, the Japanese staffing and PR firm, has acquire Exmedio. Exmedio is a Japanese health technology startup that aims to connect doctors through IT and help them provide better medical care. Exmedio's clinical problem solving service, "Hypokra" will be renamed as “Hypocra x MyNavi."
buyer: Mynavi Corporation
Mynavi is a Japanese staffing and PR firm. Their multiple services match companies with individuals of any skill level. In addition, they offer marketing and consulting services for companies looking for experts in specific fields. "
target: ExMed.io
Exmedio is a Japanese health technology startup that aims to connect doctors through IT and help them provide better medical care. They provide clinical support through their Hippokura platform, a technology that can be used by doctors in all clinical departments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/25/2018 via GlobeNewswire

Fusion, acquired IQMax, Inc.

synopsis: Fusion, a leading provider of cloud services, announced that it has acquired the software, intellectual property and customers of privately held IQMax, Inc., a pioneer in developing secure messaging, enterprise data integration and advanced cloud communications solutions.
buyer: Fusion (FSNN:$150.53)
Fusion is a leading provider of integrated cloud solutions to small, medium and large businesses. Fusion's advanced, high availability cloud service platform enables the integration of leading edge solutions in the cloud. "
target: IQMax, Inc.
IQMax, a leader in intelligent healthcare communications, provides healthcare professionals a complete suite of products specifically designed to securely communicate and collaborate in real-time for better care coordination.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/22/2016 via BusinessWire

Practice Unite merged with Uniphy Health Holdings LLC,

synopsis: Practice Unite, an innovative mobile-first healthcare communications solutions provider and Uniphy Health, a breakthrough physician engagement firm, announced the merger of their organizations to create the healthcare industry’s most comprehensive communications and collaboration solutions provider.
buyer: Uniphy Health Holdings LLC
Uniphy Health’s mobile-first solutions enable highly-effective care team collaboration and communication across the care continuum. The Uniphy Care Platform™ creates a network that aligns organizations’ acute and ambulatory care teams, skilled nursing facilities, home caregivers and patients. "
target: Practice Unite
Practice Unite® is designed to be a healthcare organization’s platform for HIPAA-compliant mobile communication and collaboration applications. Solutions are easily tailored to a healthcare organization’s unique needs, and interface with the EHR and other clinical systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/22/2020 via Company Press Release

InfoMedix, acquired Clinivid

synopsis: InfoMedix, an Australian provider of healthcare software solutions, has acquired Clinivid, a secure clinical communications app in Australia. Clinivid aims to improve the way clinicians connect, communicate and collaborate. The app allows users to securely share images, reports, video and notes with other clinicians.
buyer: InfoMedix
InfoMedix is an Australian provider of healthcare software solutions. InfoMedix's Digital Patient Chart (DPC) is a highly configurable digital medical record that enables health services to access clinical and administrative data in one place and in real-time. "
target: Clinivid
Clinivid is a secure clinical communications app in Australia. Clinivid aims to improve the way clinicians connect, communicate and collaborate. The app allows users to securely share images, reports, video and notes with other clinicians.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/27/2017 via Company Press Release

Kipu Systems LLC, acquired pingmd, Inc.

synopsis: Kipu Health LLC announced the acquisition of PingMD, a HIPAA-compliant, FIPS-certified and Privacy Shield Certified state-of-the-art messaging and Telehealth App. PingMD’s advanced technology enables patients and providers to securely, and legally, communicate via voice, text and video, and transmit data.
buyer: Kipu Systems LLC
Kipu Health is building an ecosystem of technology and media to affect the entire spectrum of the addiction treatment continuum. KipuEMR is the largest and most widely implemented EMR in the addiction treatment community, utilized by over 1,300 addiction treatment facilities and 32,000 users, "
target: pingmd, Inc.
PingMD is a HIPAA-compliant, FIPS-certified and Privacy Shield Certified state-of-the-art messaging and Telehealth App. PingMD’s advanced technology enables patients and providers to securely, and legally, communicate via voice, text and video, and transmit data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2014 via Company Press Release

Flatiron Health, will acquire Altos Solutions

synopsis: Flatiron Health, developers of the OncologyCloud™ platform, has reached an agreement to acquire Altos Solutions, Inc., a leading web-based oncology software company and developer of the OncoEMR™ electronic medical record (EMR) system.
buyer: Flatiron Health
Flatiron Health is a health care technology company and operator of the OncologyCloud platform. Integrating across the entire clinical data spectrum, it allows cancer care providers and life science companies to gain deep business and clinical intelligence through its web-based platform. "
target: Altos Solutions
Altos Solutions, Inc. is the pioneer in secure web-based oncology-specific software applications; focusing on intuitive electronic medical records, practice management with integrated medical billing, real-time comparative analytics, and patient and provider portals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/19/2021 via GlobeNewswire

Cegedim Santé, acquired Kobus Tech

synopsis: Cegedim Santé, part of Cegedim Group, is acquiring Kobus Tech, a company that publishes software specializing in the assessment and monitoring of rehabilitation patients. Since its creation in 2016, Kobus has been developing its solution in co-design with users, in order to maximize the use value of the software. They are based in France.
buyer parent: Cegedim
buyer: Cegedim Santé
Cegedim Santé is one of the 4 pillars of the Cegedim Group. They offer digital solutions and services for healthcare professionals and patients through their products CLM, RMI, Maiia, Smart RX and RESIP. "
target: Kobus Tech
Kobus Tech is a company that publishes software specializing in the assessment and monitoring of rehabilitation patients. Since its creation in 2016, Kobus has been developing its solution in co-design with users, in order to maximize the use value of the software. They are based in France.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/6/2020 via PR Web

Vetsource, acquired Vet2Pet

synopsis: Vetsource, a technology-enabled health care services company, has acquired a majority stake in Vet2Pet, the leading client engagement platform for veterinary practices. Vet2Pet’s mobile platform helps practices to grow their business and deepen the connection with their clients. It features appointment requests, automated reminders, and more.
buyer: Vetsource
Vetsource is a healthcare information technology company that provides innovative pharmacy, technology and business services to veterinarians. As the largest Home Delivery pharmacy provider to veterinarians, it sources products directly from the manufacturers. "
target: Vet2Pet
Vet2Pet is the leading client engagement platform for veterinary practices. Vet2Pet’s mobile platform helps practices to grow their business and deepen the connection with their clients. It features appointment requests, automated reminders, a loyalty program, and social media integration.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2022 via GlobeNewswire

Stryker Corporation, acquired Vocera Communications, Inc.

synopsis: Stryker has acquired Vocera Communication. Vocera provides clinical communication and workflow solutions that help protect and connect team members, increase operational efficiency, enhance quality of care and safety, and humanize the healthcare experience.
buyer: Stryker Corporation (SYK:$16,669.00)
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. "
target: Vocera Communications, Inc. (VCRA:$225.00)
Founded in 2000, Vocera provides clinical communication and workflow solutions that help protect and connect team members, increase operational efficiency, enhance quality of care and safety, and humanize the healthcare experience.
price ($mm)[EV]
$2,969 [$2,912]
rev ($mm)
$234
EBITDA ($mm)
$13
EV / rev
12.8x
EV / EBITDA
225.3x
announced 2/26/2021 via PR Newswire

Evernorth, will acquire MDLive

synopsis: Evernorth, the leading health services portfolio of Cigna, will acquire MDLIVE, a leading 24/7 virtual care delivery platform. The acquisition will provide Evernorth with a highly complementary platform that will rapidly expand Evernorth's capabilities to deliver a more affordable, convenient, and connected patient care experience.
buyer parent: CIGNA Corporation
buyer: Evernorth
Evernorth is Cigna's high-performing health services portfolio. Evernorth brings together and coordinates premier health services offerings to deliver innovative and flexible solutions for health plans, employers, and government programs. "
target: MDLive
MDLIVE offers convenient, affordable, and contagion-free virtual healthcare services to over 60 million members nationwide. MDLIVE leverages technology and artificial intelligence to simplify and streamline, connecting providers and patients whenever and wherever it's most convenient.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/11/2021 via PR Web

2ndWave Software, Providence Equity Partners Inc., acquired HealthTrio

synopsis: 2ndWave Software and PSG have acquired HealthTrio, a leading software-as-a-service innovator for the healthcare market. The investment from PSG and 2ndWave will accelerate opportunities for HealthTrio’s clients to better impact health outcomes, improve the patient experience, and decrease costs.
buyer: 2ndWave Software
buyer: Providence Equity Partners Inc.
PSG, an affiliate of Providence Equity Partners, is a growth equity firm that partners with lower middle-market software and technology-enabled services companies. 2ndWave Solutions partners with middle-market enterprise software companies to drive growth. "
target: HealthTrio
HealthTrio provides digital engagement solutions that optimize self-service, value-based care, healthcare consumerism and real-time data integration. Their tools cover eligibility, benefits, and claim, as well as advanced features supporting provider quality performance and automated authorizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2019 via PE Hub

EMV Capital Ltd, acquired Wanda Health

synopsis: EMV Capital, a London-based early-stage venture investor, has acquired Wanda Inc from NetScientific, a transatlantic healthcare IP commercialisation group. Wanda is a digital health company that offers advanced clinical decision support software powered by machine learning to improve and simplify life for people with serious health risks.
buyer: EMV Capital Ltd
EMV Capital (EMVC) is a London-based early-stage venture investor focused on B2B companies in the industrial high-tech, energy, circular economy, smart cities, transportation and healthcare sectors. EMVC’s investments cover a range of technologies, including AI, machine learning, IoT, and more. "
target parent: NetScientific
target: Wanda Health
Wanda is a digital health company. Wanda offers advanced clinical decision support software powered by machine learning and real time patient data analysis to improve and simplify life for people with serious health risks. Wanda empowers clinically guided interventions to prevent rehospitalizations.
price ($mm)
$0.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/24/2017 via BNC Analysis

BTG International Ltd., purchased Oncoverse from Wanda Health

synopsis: NetScientific said portfolio company Wanda has sold OncoVerse LLC to BTG Plc. OncoVerse is a digital health platform designed to allow cancer patients' care teams to collaborate and allow clinicians across all disciplines to work together to determine the most effective treatment plan for their patients.
buyer: BTG International Ltd. (LSE:BTG:$646.34)
BTG is focused on developing innovative products in specialist areas of medicine to better serve doctors and patients. Their growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins. "
seller parent: NetScientific
seller: Wanda Health
San Francisco-based Oncoverse, LLC is a digital health care platform company which enables health care professionals to collaborate on cancer patient care decisions, and to monitor the progress of patient therapies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/24/2017 via BNC Analysis

BTG International Ltd., purchased Oncoverse from Wanda Health

synopsis: NetScientific said portfolio company Wanda has sold OncoVerse LLC to BTG Plc. OncoVerse is a digital health platform designed to allow cancer patients' care teams to collaborate and allow clinicians across all disciplines to work together to determine the most effective treatment plan for their patients.
buyer: BTG International Ltd. (LSE:BTG:$646.34)
BTG is focused on developing innovative products in specialist areas of medicine to better serve doctors and patients. Their growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins. "
seller parent: NetScientific
seller: Wanda Health
San Francisco-based Oncoverse, LLC is a digital health care platform company which enables health care professionals to collaborate on cancer patient care decisions, and to monitor the progress of patient therapies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2021 via GlobeNewswire

Syneos Health, acquired StudyKIK

synopsis: Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the acquisition of StudyKIK, a leading technology-enabled clinical trial recruitment and retention company.
buyer: Syneos Health (INCR:$4,730.38)
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Their company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. "
target: StudyKIK
StudyKIK is a leading technology-enabled clinical trial recruitment and retention company. StudyKIK supports patient recruitment, patient retention, eConsent Solutions, Telemedicine Video Calling, and study companion mobile applications to expedite clinical trials
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Oncoverse


read more

Wanda Health

Explorer Surgical Corp.

DermEbx and Radion

Oculo

Omnyx

MedXT

VisualShare

Mammosphere

Trusst

ExMed.io

IQMax, Inc.

Practice Unite

Clinivid

pingmd, Inc.

Altos Solutions

Kobus Tech

Vet2Pet

Vocera Communications, Inc.

MDLive

HealthTrio

read more

Wanda Health

Wanda Health

read more

Wanda Health

read more

StudyKIK

Geography
Matching Companies
Ticker: OM:PTRK
 
 
 
 
 
 
 
 
Physitrack
Physitrack
Physitrack is an Apple Mobility Partner and the world leader in the provision of Virtual Care and Telehealth technology. Physitrack works with tens of thousands of public and private healthcare providers around the world helping them care for several million patients per year.
year
2021
rev ($mm)
$8.23
EBITDA ($mm)
$1.12
EBIT ($mm)
$1.09
Net Income ($mm)
Employees
49
  • drill down
  • watch
Ticker: OTCPK:SOLI
 
 
 
 
 
 
 
 
CareClix
CareClix
CareClix Holdings, Inc is a telemedicine software and services company centered around the CareClix® virtual telehealth platform. The CareClix Group of companies provides software applications coupled with medical services enabling patients to receive care anytime at anyplace.
year
2019
rev ($mm)
$1.52
EBITDA ($mm)
($19.58)
EBIT ($mm)
($19.68)
Net Income ($mm)
Employees
20
  • drill down
  • watch
Ticker: ASX:VRI
 
 
 
 
 
 
 
 
Veriluma Limited
Veriluma Limited
Veriluma is an innovative Australian software company founded in 2010. Veriluma’s patented algorithm was originally developed for the Australian Department of Defence where situations can lack certainty and reliable information and may depend on input that is subjective.
year
2019
rev ($mm)
$0.58
EBITDA ($mm)
($0.24)
EBIT ($mm)
($0.24)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: ASX:M7T
 
 
 
 
 
 
 
 
Mach7 Technologies.
Mach7 Technologies.
Mach 7 Technologies is a global provider of enterprise image management systems and services that allow healthcare enterprises to easily identify, connect, and share diagnostic image and patient care intelligence where and when it is needed.
year
2019
rev ($mm)
$10.26
EBITDA ($mm)
EBIT ($mm)
($1.79)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: AIM:INHC
 
 
 
 
 
 
 
 
Induction Healthcare Group PLC
Induction Healthcare Group PLC
Induction Healthcare is a healthcare technology company in the UK. Induction Healthcare offers a secure communications toolkit that allows healthcare professionals to connect with the people they need, collaborate in teams and communicate securely in complex clinical environments.
year
2019
rev ($mm)
EBITDA ($mm)
($3.63)
EBIT ($mm)
($3.65)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
American Well Corporation
Amwell is a leading telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare.
year
2021
rev ($mm)
$249.15
EBITDA ($mm)
($230.04)
EBIT ($mm)
($240.42)
Net Income ($mm)
Employees
812
  • drill down
  • watch
Ticker: ASX:RAP
 
 
 
 
 
 
 
 
ResApp Health
ResApp Health
ResApp Health is a mobile telehealth solution based in Australia. ResApp Health assists doctors and empowers patients to diagnose and manage respiratory disease. Their solution allows doctors to instantly diagnose respiratory diseases from the sound of their patient’s cough or breathing.
year
2021
rev ($mm)
$0.05
EBITDA ($mm)
($4.93)
EBIT ($mm)
($5.04)
Net Income ($mm)
Employees
510
  • drill down
  • watch
Ticker: OB:CSAM
 
 
 
 
 
 
 
 
CSAM Health AS
CSAM Health AS
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care.
year
2021
rev ($mm)
$34.31
EBITDA ($mm)
$3.97
EBIT ($mm)
($2.02)
Net Income ($mm)
Employees
282
  • drill down
  • watch
Ticker: KOSDAQ:A263700
 
 
 
 
 
 
 
 
Carelabs Co., Ltd.
Carelabs Co., Ltd.
Carelabs is a South Korea-based digital beauty and healthcare company. CareLabs provides comprehensive healthcare IT services, including clinic information services, clinic customer management software, and digital marketing solutions.
year
2019
rev ($mm)
$49.51
EBITDA ($mm)
$4.38
EBIT ($mm)
$3.14
Net Income ($mm)
$1.79
Employees
0
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: CPSI
 
 
 
 
 
 
 
 
CPSI
CPSI
CPSI is a leading provider of healthcare solutions and services for community hospitals, their clinics and post-acute care facilities. Founded in 1979, CPSI is the parent of three companies – Evident, LLC, American HealthTech, Inc. and TruBridge, LLC.
year
2021
rev ($mm)
$262.74
EBITDA ($mm)
$33.37
EBIT ($mm)
$19.84
Net Income ($mm)
$14.30
Employees
2000
  • drill down
  • watch
Ticker: TSXV:NGH
 
 
 
 
 
 
 
 
Nightingale Informatix Corporation
Nightingale Informatix Corporation
For more than a decade, Nightingale has been delivering innovative cloud-based Electronic Health Record and Practice Management solutions to healthcare organizations across the United States and Canada. They create software that is truly intuitive—minimizing training and maximizing adoption.
year
2015
rev ($mm)
$9.64
EBITDA ($mm)
($1.47)
EBIT ($mm)
($2.00)
Net Income ($mm)
$1.47
Employees
120
  • drill down
  • watch
Ticker: OTCPK:HNSS
 
 
 
 
 
 
 
 
Healthnostics, Inc.
Healthnostics, Inc.
Healthnostics, Inc. is a medical and biotechnology analytics company that provides patient clinical monitoring and risk management systems to acute care hospitals, and utilizes its Internet portals to deliver medical and biotechnology resource information.
year
2012
rev ($mm)
$0.20
EBITDA ($mm)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: PFE
 
 
 
 
 
 
 
 
Pfizer, Inc.
Pfizer, Inc.
Pfizer is the world's largest research-based biopharmaceutical company. Pfizer applies science and their global resources to deliver innovative therapies that improve lives. The company has a portfolio of medicines that prevent, treat and cure diseases across a broad range of therapeutic areas.
year
2022
rev ($mm)
$81,288.00
EBITDA ($mm)
$30,793.00
EBIT ($mm)
$25,602.00
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: DB:MRK
 
 
 
 
 
 
 
 
Merck KGaA
Merck KGaA
Merck KGaA is a German multinational pharmaceutical, chemical and life sciences company. Merck is the world's oldest operating chemical and pharmaceutical company. The group develops a variety of prescription medicines and specialty chemicals.
year
2019
rev ($mm)
$17,234.26
EBITDA ($mm)
$4,219.33
EBIT ($mm)
$2,268.49
Net Income ($mm)
$3,866.88
Employees
53051
  • drill down
  • watch
Ticker: LSE:BTG
 
 
 
 
 
 
 
 
BTG International Ltd.
BTG is focused on developing innovative products in specialist areas of medicine to better serve doctors and patients. Their growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins.
year
2016
rev ($mm)
$646.34
EBITDA ($mm)
$150.64
EBIT ($mm)
$89.00
Net Income ($mm)
$28.38
Employees
1370
  • drill down
  • watch
Ticker: BSE:531637
 
 
 
 
 
 
 
 
Sword and Shield Pharma Ltd.
Sword and Shield Pharma Ltd.
Sword & Shield Pharma is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. They offer a portfolio of products including Active Pharmaceutical Ingredients, generics, differentiated formulations and News Chemical Entities.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ABC
 
 
 
 
 
 
 
 
AmerisourceBergen Corporation
AmerisourceBergen Corporation
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust them as their partner in the pharmaceutical supply chain.
year
2019
rev ($mm)
$175,151.50
EBITDA ($mm)
$2,276.42
EBIT ($mm)
$1,735.61
Net Income ($mm)
$929.88
Employees
20500
  • drill down
  • watch
Ticker: ADRX
 
 
 
 
 
 
 
 
Andrx Corporation
Andrx Corporation is committed to providing: high quality, cost effective pharmaceuticals to our customers and to patients; sustained profit and revenue growth to our stockholders; and an employee culture that is stimulating and rewarding.
year
2005
rev ($mm)
$1,145.10
EBITDA ($mm)
$132.00
EBIT ($mm)
$95.90
Net Income ($mm)
$65.70
Employees
0
  • drill down
  • watch
Ticker: MDZ
 
 
 
 
 
 
 
 
MDS, Inc.
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
year
2009
rev ($mm)
$231.00
EBITDA ($mm)
$37.00
EBIT ($mm)
$13.00
Net Income ($mm)
Employees
3600
  • drill down
  • watch
Ticker: ABPI
 
 
 
 
 
 
 
 
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the development of Revimmune as a system of care for the treatment of autoimmune diseases. The company, through its subsidiary, Biovest International, Inc.
year
2012
rev ($mm)
$4.05
EBITDA ($mm)
($11.29)
EBIT ($mm)
($11.54)
Net Income ($mm)
Employees
54
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Novartis AG
Novartis AG
Novartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales. Their focus is on cancer, immunology, dermatology, cardiovascular, renal and more.
year
2019
rev ($mm)
$48,677.00
EBITDA ($mm)
$15,532.00
EBIT ($mm)
$11,351.00
Net Income ($mm)
$11,732.00
Employees
103914
  • drill down
  • watch
Ticker: OTCPK:PRLX
 
 
 
 
 
 
 
 
Parallax Health Sciences, Inc.
Parallax Health Sciences, Inc. is an innovative biomedical healthcare company delivering consumer-centric products and services in the areas of pharmaceuticals, digital health and remote patient monitoring, behavioral health and point of care diagnostics.
year
2016
rev ($mm)
$18.98
EBITDA ($mm)
($1.31)
EBIT ($mm)
($1.43)
Net Income ($mm)
Employees
34
  • drill down
  • watch
Ticker: RVNC
 
 
 
 
 
 
 
 
Revance Therapeutics, Inc.
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection.
year
2020
rev ($mm)
$0.19
EBITDA ($mm)
($185.77)
EBIT ($mm)
($188.79)
Net Income ($mm)
Employees
193
  • drill down
  • watch
Ticker: ZTS
 
 
 
 
 
 
 
 
Zoetis
Zoetis
Zoetis is a global animal health company. Zoetis develops, manufactures and commercializes medicines, vaccines and diagnostic products. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals.
year
2019
rev ($mm)
$6,260.00
EBITDA ($mm)
$2,578.00
EBIT ($mm)
$2,193.00
Net Income ($mm)
$1,500.00
Employees
10600
  • drill down
  • watch
Ticker: PGNX
 
 
 
 
 
 
 
 
Progenics Pharmaceuticals
Progenics Pharmaceuticals
Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. They offer a first-in-class PSMA-targeted technology platform for prostate cancer.
year
2015
rev ($mm)
$43.27
EBITDA ($mm)
($0.54)
EBIT ($mm)
($1.07)
Net Income ($mm)
$2.85
Employees
57
  • drill down
  • watch